The #SBIR/#STTR #NIH, #CDC, and #FDA solicitation open

  • Friday, May 10, 2019 7:00 PM

The 2019 #SBIR and #STTR Omnibus/Parent #Grant Solicitations for the #NIH, #CDC, and #FDA was recently released. Wondering what they will fund?

Be sure to pay close attention to the slight differences between #NIH, #CDC, #FDA, and between #SBIR and #STTR, as well as “clinical trial allowed” or “not allowed”. Each has specific requirements that are unique to the solicitation line. Need help determining whether you are doing a clinical trial?

Please note that all proposals are due by 5:00 PM local time of applicant organization on September 5 for Cycle I, January 5 for Cycle II, and April 5 for Cycle III.

Approved 2019 Program Descriptions and Research Topics Documents are here (PDF 2.31 MB) (MS WORD 614 KB), be sure that what you are proposing fits within the approved topics list.

  • #NIH, #CDC, and #FDA’s #SBIR (PA-19-272) – clinical trials are NOT ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track (NIH-only)),
    • New (SBIR Direct Phase II – NIH Only),
    • Renewal (Phase II),
    • Resubmission (all phases),
    • Renewal (Phase IIB)
  • #NIH, #CDC, and #FDA’s #STTR (PA-19-270) – clinical trials are NOT ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track)
    • Renewal (Phase II* Direct Phase II NOT allowed)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision
  • #NIH, #CDC, and #FDA’s #SBIR (PA-19-273) – clinical trials ARE ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track (NIH-only))
    • New (SBIR Direct Phase II – NIH Only)
    • Renewal (Phase II)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision
  • #NIH, #CDC, and #FDA’s #STTR (PA-19-271) – clinical trials ARE ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track)
    • Renewal (Phase II* Direct Phase II NOT allowed)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision

We are your single source for all your non-dilutive grant funding activities. From identification of relevant funding opportunities through the development of a long-term multi-submission approach to successful execution, and subsequent measuring of your outcomes from your award! We can help you locate funding, apply for funding, and help organizations measure & report on outcomes. Schedule a consult call with us HERE.

error: Content is protected !!